December 2012
·
17 Reads
·
17 Citations
The chapter is divided into groups by different types of addictive substances withparticular respect to specific features pertaining to the potential risks of the developmentof cognitive deficits associated with the use thereof. Considerably greater attention ispaid to some of the substances, as the users of such substances and the consequences ofusing them are encountered more frequently in practice. For example, this emphasis wasapplied for cannabis and MDMA ("ecstasy"), as these are substances that have becomevery popular among adolescents and young adults, and there are no signs of any majorreversal of this tendency. Significant attention was also paid to the group of stimulantswhose risk in terms of cognitive deficits is unfortunately often underestimated in practice,as opposed to the risk associated with opioid use, which, conversely, is overestimated. Aseparate area of concern involves volatile substances whose significant risks, includingthose to cognitive functions, are well known-the professional community has beenpointing this issue out-but these facts are not adequately reflected in writings publishedin professional journals, nor in other messages. Finally, the concluding section of thechapter deals with assessment methods and recommended procedures for theidentification and proposal of treatment and rehabilitation interventions aimed ataddressing cognitive deficits caused by addictive substance use.